Quality of Life of patients with chronic kidney disease in Iran: Systematic Review and Meta-analysis by Ghiasi, Ghiasi et al.
See discussions, stats, and author profiles for this publication at: https://www.researchgate.net/publication/323182818
Quality of Life of patients with chronic kidney disease in Iran: Systematic Review
and Meta-analysis
Article  in  Indian Journal of Palliative Care · January 2018
DOI: 10.4103/IJPC.IJPC_146_17
CITATIONS
3
READS
80
5 authors, including:
Some of the authors of this publication are also working on these related projects:
Quality of Life among Iranian Infertile Women in Postmenopausal Period: A Cross-sectional Study View project
Molecular emipediology View project
Diana Sarokhani
Islamic Azad University Kermanshah Branch
29 PUBLICATIONS   78 CITATIONS   
SEE PROFILE
Ali Hassanpour Dehkordi
Shahrekord University of Medical Sciences
58 PUBLICATIONS   376 CITATIONS   
SEE PROFILE
Kourosh Sayehmiri
Ilam University of Medical Sciences
369 PUBLICATIONS   1,096 CITATIONS   
SEE PROFILE
Mohammad Hossein Heidari
Shahid Beheshti University of Medical Sciences
15 PUBLICATIONS   78 CITATIONS   
SEE PROFILE
All content following this page was uploaded by Diana Sarokhani on 14 May 2018.
The user has requested enhancement of the downloaded file.
© 2018 Indian Journal of Palliative Care | Published by Wolters Kluwer - Medknow104
Systematic Review
IntroductIon
Quality of life is an important criterion that illustrates the 
effectiveness of health care, health level, and well-being. It 
is a multidimensional concept that includes ability, function, 
health, well-being, and psychological state, which is defined by 
the World Health Organization as values, goals, standards, and 
individual interests.[1-4] There is a relationship between diseases 
and quality of life. Quality of life can have a direct impact 
on physical performance, emotional, and physical problems, 
fatigue, mental health, social performance, physical pain, 
and general health.[5-10] Therefore, knowledge about chronic 
diseases, especially chronic kidney diseases (CKD) is very 
important in the evolution of patients’ health problems.[11-14]
CKD is one of the major public health problems worldwide.[15-17] 
The incidence of chronic renal failure in the world is 242 cases 
per a million people, and 8% is added to this population each 
year.[18,19] The population of patients with renal failure in Iran 
is 320,000.[20,21] One of the ways to improve the condition 
of patients with chronic renal failure is hemodialysis.[18,22] 
In addition to hemodialysis, peritoneal dialysis and kidney 
transplantation are the common alternative treatments.[23] The 
patients undergoing dialysis have to spend several hours of their 
lives in dialysis sessions (2–3 sessions each week), and these 
constraints affect the living conditions of these patients.[18,24] 
In general, patients with CKD are affected by a wide range of 
physical, psychological, economic, and social problems[11,25-29] 
which ultimately influence their quality of lives.[30]
Considering the contradictory results of previous studies 
and the importance of “quality of life” and its effects on the 
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personal and social life in patients with CKD, the present study 
was carried out through meta-analysis to provide a general 
assessment of the quality of life of CKD patients in Iran.
MaterIals and Methods
Search strategy
In this study, the quality of life in patients with CKD in Iran 
was examined using a systematic review and meta-analysis. To 
access the relevant Persian and English articles, national and 
international databases including IranMedex, SID, Magiran, 
IranDoc, Medlib, ScienceDirect, Pubmed, Scopus, Cochrane, 
Embase, Web of Science, and Medline were searched using 
related Persian keywords and their English equivalent 
(“Iran,” “CKD Patients,” “CKD,” “Quality of Life”) along 
with the logical combinations of these keywords. The Google 
Scholar search engine was also used to find relevant articles. 
References of related articles were searched to come up with 
an exhaustive search.[11,25-29] The search was done on databases 
from 2005 to May 2017.
Inclusion and exclusion criteria
The inclusion criteria referred to the quality of life in patients 
with CKD in Persian and English from 2000 to 2017. The 
exclusion criteria included nonrandom sampling, insufficient 
data, and statistical population other than in patients with CKD.
In the first stage, 231 articles on the quality of life in patients 
with CKD were found. After reviewing the titles, 113 articles 
were excluded due to the problem of duplication. The abstracts 
of all remaining articles were reviewed, and 39 irrelevant 
articles were omitted. The full texts of the remaining articles 
were reviewed, and 34 articles were excluded in conformity 
with the exclusion criteria. In the end, 45 articles entered the 
qualitative assessment process [Chart 1].
Qualitative assessment of studies
To assess the quality of studies, the preferred reporting items 
for systematic review and meta-analysis,[31] which is a checklist 
specifically designed for meta-analyses and systematic 
reviews, were used.
Data extraction
Two researchers independently extracted the data from the 
sources to minimize the errors in data reporting, and thereby 
increase the accuracy of the gleaned data. The researchers 
designed a checklist for extracting data from the sources 
(the items of researcher-made checklist were the name of the 
first author, the purpose of the study, the number of samples, 
the year and place of research, the type of kidney disease, the 
type of quality of life questionnaire, the average age of the 
individuals, and mean and standard deviation (SD) of different 
dimensions of the quality of life in in patients with CKD). 
Questionnaires used in the studies included the following:
SF-36 standard questionnaire
This is a short 36-item form consisting of two parts; the first 
part comprises demographic information, and the second 
part contains 11 questions that examine different aspects of 
health pertaining to quality of life. In fact, the second part of 
theSF-36 questionnaire is the same as health-related quality 
of life (HRQOL). These aspects include social function, 
limitations in the role due to physical problems, pain, mental 
health, limitations in the role due to emotional problems, and 
overall understanding of general health. Questions were rated 
by Likert Scale and ranged from 0 to 100, where higher points 
indicate a more favorable situation.[32-35]
The kidney disease quality of life-short form (KDQOL-SF) 
questionnaire, which is a multidimensional questionnaire 
that includes SF-36 questions and questions on CKD. The 
questionnaire assesses 12 factors of health and quality of life, 
including physical function, general health, the effects of CKD 
on life, imposed conditions, pain, sleep, social function, social 
support, energy, emotional roles, sexual function, and patient’s 
satisfaction. Questions were rated from 0 to 100, where higher 
points indicate more favorable conditions.[36,37]
Kidney disease quality of life-short form TM questionnaire
This questionnaire is a specific tool for assessing the quality 
of life in hemodialysis patients and includes two general and 
specific scales on the quality of life. The general quality of 
life scale consists of two subscales of physical conditions and 
emotional conditions. The physical subscale contains four areas 
of general health (with 6 items), physical function (10 items), 
playing physical role (including 4 items), and physical 
pain (including 3 items). The subscale comprised emotional 
conditions comprising three areas of playing emotional 
role (3 items), social function (including 2 items), and mental 
health (including 8 items). The specific dimension of the 
research tool consisted of nine areas including CKD-related 
constraints (11 items), health-related mental problems 
(6 items), health-related physical function (12 items), general 
health (3 items), health-related family satisfaction (4 items), 
sleep status (score from 0 to 100), health-related occupational 
status (3 items), sexual issues (2 items), and satisfaction with 
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One additional record identified
through other sources
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39 records excluded
79 full-text articles
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(meta-analysis)
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Chart 1: Flowchart of steps involved in entering the studies into the 
systematic review and meta‑analysis process
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care and ward staff (3 items). Each area has 100 points. This 
questionnaire is a multidimensional, valid, and reliable tool 
that addresses all aspects of the SF-36 questionnaire.[38]
Statistical analysis
The reviewed studies were combined based on the number of 
samples, mean, and SD. The standard error of the mean was 
calculated using SD/sqrt (n) equation according to the normal 
distribution. To evaluate the heterogeneity of the studies, Q test 
and I2 index were used. Due to the heterogeneity in the studies, 
the random-effects model was used to combine the results of 
the studies. The significance level of the test was considered 
P < 0.05. Data were analyzed using  Stata is a general-purpose 
statistical software package created in 1985 by StataCorp. 
Most of its users work in research, especially in the fields 
of economics, sociology, political science, biomedicine and 
epidemiology
results
In 45 studies with a sample size of 17,200 people, the mean 
score of “quality of life” in CKD patients based on SF-36 
questionnaire was 60.31% (95% confidence interval [CI]: 
69.00%–51.62%), it was 51.60% (95% CI: 53.45%–49.75%) 
according to HRQOL questionnaire and 50.37% (95% CI: 
54.77%–45.96%) based on KDQOL-SF questionnaire. 
Considering the heterogeneity of the studies in focus, the CI 
for each study based on the random effects model is presented 
in Figure 1 and Tables 1,2.
dIscussIon
In 45 studies with a sample size of 17,200 people, the mean 
score of the quality of life in patients with CKD based on 
SF-36, HRQOL, and KDQOL-SF questionnaires was 60.31, 
51.60, and 50.37%, respectively. However, the mean score 
of the “quality of life” based on KDQOL-SFTM and KDQOL 
questionnaires was not calculated since each of them was only 
used in a single study
According to meta-regression diagram, there is no significant 
relationship between the quality of life in patients with CKD 
and the number of research samples, that is, with an increase in 
the number of research samples, the mean score of the quality 
of life in patients with CKD decreased, but this reduction is 
not statistically significant (P = 0.502). In the above diagram, 
the size of the circle shows the magnitude of the sample 
size [Figure 2]. In Figure 3, meta-regression model showed 
that there is no significant relationship between the quality of 
life in patients with CKD and the year of study. In other words, 
NOTE: Weights are from random effects analysis
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Figure 1: Average quality of life in patients with chronic kidney disease in Iran (95% confidence interval) based on questionnaire according to random 
effects model. The middle point of each segment shows the quality of life score in chronic kidney disease patients in each study
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Table 1: Specifications of the articles reviewed on quality of life in chronic kidney diseases patients in Iran
References Author Year City Age 
mean
Type of 
questionnaire
Type of disease Sample 
size
QOL 
mean
QOL 
SD
[39] Zargooshi 1989-2000 Kermanshah 33 SF-36 Donors and patients 
underwent nephrectomy
400 - -
[40] Nourbala et al. 2006 Tehran 49.53 HRQOL Kidney recipients 164 52.5 9.79
[41] Noohi et al. 2005 Tehran 43.37 HRQOL Kidney transplant 162 53.32 9.95
[42] Kachuee et al. 2006 Tehran 42 SF-36 Kidney transplant 125 54.04 10.05
[43] Noohi et al. 2005-2006 Tehran 42.05 SF-36 Kidney transplant 88 52.37 10.12
[44] Baghaei et al. 2011 Guilan >18 SF-36 Hemodialysis 241 54 13.33
[45] Taheri et al. 2011 Khorramshahr-Abadan 47.43 KDQOL-SF Hemodialysis 80 47.22 8.89
[46] Yekaninejad et al. 2012 Sari-Zanjan-Tehran 57.5 KDQOL-SF Hemodialysis 212 - -
[47] Shakoor and Hassan 
Sadeghi
2015 Shiraz 20-50 SF-36 Kidney transplant 44 -1.28 8.78
[48] Kaviani et al. 2012 Ahvaz 56 SF-36 End stage patients and 
hemodialysis
122 46.85 21.2
[49] Baljani et al. 2014 Urmia 47.08 KDQOL-SF™ Hemodialysis 82 - -
[50] Hadi et al. 2010 Shiraz - SF-36 CKD under hemodialysis 120 - -
[51] Fardinmehr et al. 2011 Isfahan 52.7 KDQOL-SF End stage renal disease 50 54.7 21.8
[52] Ramezani Badr et al. 2011 Zanjan 51.8 KDQOL Hemodialysis 74 - -
[53] Fallahzadeh et al. 2011 Shiraz 38.35 SF-36 Kidney donors 144 - -
[54] Pakpour et al. 2012 Qazvin-Tehran 57.8 SF-36 Hemodialysis 512 - -
[55] Malekahmadi et al. 2006 Tehran 14.2 SF-36 Kidney recipients 55 65.39 14.11
[56] Raiisifar et al. 2009 Tehran 41 SF-36 Kidney transplant 218 60.6 18.7
[21] Abbaszadeh et al. 2008-2009 Kerman 41.98 SF-36 Kidney transplant and 
hemodialysis
120 89.54 58.16
[57] Tayyebi et al. 2008 Tehran 44.88 SF-36 Kidney transplant and 
hemodialysis
76 - -
[58] Moeinzadeh et al. 2016 Isfahan 58.05 KDQOL-SF Hemodialysis 52 55.5 14.75
[59] Aghakhani et al. 2007 Urmia 38.72 SF-36 Hemodialysis 166 60.21 18.21
[60] Rostami et al. 2010-2011 - 55 KDQOL-SF Hemodialysis patients 
with viral hepatitis
4101 43.69 16.99
[61] Hemmati Maslakpak 
and Shams
2013 Urmia 47.03 KDQOL-SF Hemodialysis 120 54.7 16.63
[62] Parvan et al. 2012 Tabriz 58.03 SF-36 Hemodialysis 245 48.4 11.9
[63] Emami Naeini et al. 2012 Isfahan 52.78 HRQOL Hemodialysis 51 46.65 19.08
[64] Rostami et al. 2010-2011 - 54.4 SF-36 Hemodialysis 6930 44.29 17.7
[65] Taheri-Kharameh 
et al.
2012-2013 Qom 50.4 SF-36 Hemodialysis 95 - -
[66] Heidarzadeh et al. 2008 Bonab 50.2 SF-36 Hemodialysis 115 131.3 21.1
[67] Aghakhani et al. 2012 Urmia 45.2 SF-36 Hemodialysis 70 - -
[68] Shahgholian et al. 2014 Isfahan 50.4 KDQOL-SF Hemodialysis 25 48.1 10.6
[69] Hajian-Tilaki et al. 2014 Babol 54.2 SF-36 Hemodialysis 154 - -
[70] Pakpour et al. 2008 Tehran 53.63 SF-36 Hemodialysis 250 - -
[71] Tayyebi et al. 2012 Tehran 41.24 SF-36 Kidney transplant 220 60.6 18.7
[72] Arab et al. 2011 Mashhad 18-70 SF-36 Hemodialysis 93 - -
[73] Dashti-Khavidaki 
et al.
2010-2011 Tehran 53.6 HRQOL Hemodialysis 92 53.2 20.2
[22] Zamanzadeh et al. 2005 Tabriz 51.9 SF-36 Hemodialysis 164 139.5 24.46
[74] Sharif and Vedad 2007 Shiraz >15 SF-36 Hemodialysis 90 - -
[75] Moghareb et al. 2012 Birjand 18-70 SF-36 Kidney transplant and 
hemodialysis
118 54.3 14.89
[76] Edalat Nejad and 
Qlich Khani
2013 Arak 63 SF-36 Hemodialysis 115 44.7 14.15
[77] Baraz et al. 2004-2005 Tehran 61.4 SF-36 CKD 85 - -
[10] Soleymanian et al. 2012 Tehran 56 HRQOL Hemodialysis 532 49.81 20.66
[78] Zeraati et al. 2009 Mashhad 47.22 SF-36 Hemodialysis 80 53.56 19.26
[79] Fouladi et al. 2012 Isfahan 54.5 SF-36 Hemodialysis 96 39.7 21.64
[80] Namdar et al. 2010 Jahrom 56.48 SF-36 Dialysis 52 50.38 15.8
SF-36: 36-Item short form, HRQOL: Health-related QOL, KDQOL-SF: Kidney disease QOL-SF, QOL: Quality of life, SD: Standard deviation, CKD: Chronic 
kidney diseases
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during the studied years, the quality of life in patients with 
CKD in Iran has decreased, but this decline is not statistically 
significant (P = 0.07).
Different studies show that quality of life in patients undergoing 
dialysis in Iran is lower than that of other chronic diseases.[81] In 
a study by Vázquez et al. in 2004, there were clear differences 
between men and women with CKD compared to the normal 
population in terms of quality of life (physical function, 
limited role due to mental problems, social function, and 
general health), while women had a worse situation.[82] In 
another study, among hemodialysis patients in Saudi Arabia 
in 2011, AL-Jumaih et al. showed that the majority of patients 
had limited physical role, emotional role, job status, and 
cognitive function and had poor quality of life.[83] In a study 
by Nonoyama et al. in Toronto, Canada, it was found that 
the majority of hemodialysis patients had average quality of 
Table 2: The mean score of the quality of life in patients with chronic kidney diseases in Iran based on the type of 
questionnaire
Type of questionnaire Subgroups Number of study Sample size QOL mean
QOL in CKD patients 
based on SF-36
Total 19 9314 60.31 (51.62-69)
Physical 28 11,097 50.59 (45.67-55.51)
Mental-psychological 23 10,543 47.32 (40.84-53.81)
Social and occupational 27 10,585 52.85 (41.57-64.14)
Vitality 23 10,146 46.64 (34.48-58.79)
General health 24 10,236 46.15 (40.48-51.82)
Physical pain 24 10,236 52.35 (42.28-62.42)
Playing a physical role 9 8319 37.14 (25.07-49.20)
Emotional 10 8560 47.68 (42.57-52.79)
Role limitation for physical causes 14 1841 42.99 (28.87-57.11)
Role limitation to emotional causes 12 1577 46.21 (27.14-65.28)
Mental health 4 361 51.38 (43.67-59.10)
QOL in CKD patients 
based on HRQOL
Total 5 1001 50.37 (45.96-54.77)
Physical 4 909 57.30 (45.23-69.16)
Mental-psychological 4 909 50.50 (45.98-55.02)
Social and occupational 3 858 49.83 (48.36-51.31)
Vitality 2 694 44.28 (36.76-51.81)
General health 3 784 47.73 (45.71-49.75)
Physical pain 3 784 43.24 (25.32-61.17)
Playing a physical role 1 532 48.61 (46.00-51.22)
Emotional 1 532 56.14 (53.12-59.16)
Role limitation for physical causes 2 326 62.16 (58.26-66.07)
Role limitation to emotional causes 2 326 63.04 (60.19-65.88)
Mental health 2 326 44.34 (43.36-45.33)
QOL in CKD patients 
based on KDQOL-SF
Total 6 4428 50.37 (45.96-54.77)
Physical 4 4443 38.28 (32.80-43.75)
Mental-psychological 3 4363 52.52 (47.20-57.84)
Social and occupational 4 4443 55.90 (53.11-58.69)
Vitality 4 4443 44.51 (40.4048.62)
General health 5 4563 43.69 (41.41-45.97)
Physical pain 4 4443 54.61 (48.09-61.13)
Playing a physical role 2 4181 39.48 (12.02-66.95)
Emotional 2 4181 34.30 (33.15-35.44)
Role limitation for physical causes 2 262 23.09 (18.75-27.44)
Role limitation to emotional causes 2 262 37.28 (15.58-58.97)
KDQOL-SF: Kidney disease QOL-SF, CKD: Chronic kidney diseases, HRQOL: Health-related QOL, SF-36: 36-Item short form, QOL: Quality of life
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Figure 2: The relationship between quality of life in chronic kidney disease 
patients and number of research samples using meta‑regression
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life.[84] In a study by Chow and Wong, dialysis patients had 
the lowest quality of life scores in terms of physical health, 
social function, and dimensions of CKD including job status 
and burden of the disease.[85] In studies conducted by Cleary 
and Drennan and Vasilieva, the mean score for physical and 
mental health was low and patients had poor quality of life.[86,87]
The mean score of diabetic patients’ quality of life in Iran 
estimated by SF-36 was 59.94 (CI 95%: 36.78–83.10).[88] 
The mean score of heart patients’ quality of life in Iran was 
42.09 (CI 95%: 19.90–64.29).[89] Among 17 accomplished 
studies in Iran with the sample size of 1476 from 2003 to 2015, 
the average quality of life score for patients with cancer in Iran 
was 42 (CI 95%: 34.05–49.96).[90]
In other studies conducted in Iran, people over 50 had 
significantly lower scores in physical, psychological, and 
renal domains compared with younger people.[91] In the study 
of Baraz et al., the highest scores of quality of life before 
intervention were related to physical function (60.3%) and social 
function (60%). The lowest scores were those of emotional 
role (41.9%) and health perception (43.5%).[92] A study by 
Namadi and Movahhedpour demonstrated that 52.1% of 
hemodialysis patients had a moderate quality of life.[93] In a study 
by Raiisifar et al., the quality of life in patients who underwent 
kidney transplantation in Tehran in 2009 was assessed; they 
found that the mean and SD of quality of life was 60.6%.[56] 
Considering the different accessible data for the quality of life 
in patients with CKD, we used the meta-analysis method to 
obtain an accurate estimate of the quality of life in these patients.
Limitations of the study
Due to the different types of questionnaires used in the 
reviewed articles, the difference in scoring the questions of the 
respective questionnaires, and the difference in the number of 
questions in questionnaires, we could not combine the results 
of different questionnaires and report accurate statistics on the 
quality of life in patients with CKD in general and for various 
dimensions. Because of the variety of questionnaires, we did 
not manage to estimate the average score of the quality of life 
in patients with CKD in terms of type of disease, age, and 
place of research.
conclusIon
The mean score for quality of life of patients with CKD was 
estimated by SF-36 (60.31), HRQOL (60.51), and KDQOL-SF 
(50.37) questionnaires. In addition, meta-regression showed 
that the mean score of these patients’ quality of life has not 
significantly decreased during the past few years. The mean 
score of quality of life for patients with CKD was lower in 
different dimensions in comparison with that of normal people. 
The mean score of quality of life of patients with CKD in Iran 
was more than those of patients with heart diseases, diabetic 
patients, and patients with cancer.[94,95] Therefore, interventional 
measures should be taken to improve the quality of life of these 
patients in all dimensions.
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